Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,002 public trials 569 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Recruiting

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

NCT07582432

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations
  • Study Site 102 St. Petersburg, Florida, United States
  • Study Site 101 Fort Wayne, Indiana, United States
  • Study Site 105 Westbrook, Maine, United States
  • Study Site 104 Columbus, Ohio, United States
View Trial Details
Recruiting

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT06896916

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Beverly Hills Cancer Center /ID# 266921 Beverly Hills, California, United States
  • Colorado Blood Cancer Institute /ID# 273751 Denver, Colorado, United States
  • Washington University /ID# 266972 St Louis, Missouri, United States
  • Rutgers Cancer Institute of New Jersey /ID# 266833 New Brunswick, New Jersey, United States
View all 27 locations
View Trial Details

Related conditions